Share This Article:

Future of Treatment of Temporomandibular Joint Dysfunctions in Parkinsonian Patients

Abstract Full-Text HTML Download Download as PDF (Size:440KB) PP. 208-227
DOI: 10.4236/ojst.2014.44030    2,631 Downloads   3,507 Views   Citations

ABSTRACT

The purpose of the study was designed to clarify the modern trends of physical therapy in treatment of temporomandibular joint dysfunctions in Parkinsonian patients, which in this respect included the degree of pain, the muscles power of both masseter and pterygoid, the range of TMJ motion, the angle of mouth opening and their effects on electromyography study in both sexes. Subjects: Thirty males and females were the same degree of disabilities according to modified Hoehn and Yahr scales (grade 3) of Parkinsonian patients, and their age ranged from 50 - 77 years old and their weight ranged from 60 - 88 kg. They were randomly divided into two equal groups (G1 and G2). G1 (control) consisted of 15 patients of both sexes and was treated by exercises therapy program and G2 (experimental) consisted of 15 Parkinsonian patients of both sexes and was treated by the same exercises therapy program and low level pulsed electromagnetic therapy. Vital signs such as blood pressure, body temperature, pulse rate and respiratory rate were measured before and after the treatment sessions. Assessments: Visual analogue scale was used to measure degree of pain. Tensiometer was used to measure the muscle power of masseter and pterygoid, the digital goniometer was used to investigate the range of TMJ movement. Moreover, standard electromyography test (EMG) was used to measure the compound muscle action potentials. Statistically the results for all groups were analyzed by t-test to compare the differences between the two groups. The statistical package of social sciences (SPSS, version 10) was used for data processing using the P-value 0.05 as a level of significance. Results showed that there were significant improvements in all variables in G2 only. However, there was a little improvement but not significant in both G1. Therefore, it could be concluded that the use of low level pulsed electro-magnetic therapy combined with exercises program was the good method to control pain of TMJ, increase of muscle power and the range of their movements together with determination of electro-myography. Our results opened a new link to manage the TMJ dysfunctions in Parkinsonian patients via the use of low level pulsed electromagnetic therapy combined with exercises program.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Nofal, R. , Altaweel, A. and Seada, Y. (2014) Future of Treatment of Temporomandibular Joint Dysfunctions in Parkinsonian Patients. Open Journal of Stomatology, 4, 208-227. doi: 10.4236/ojst.2014.44030.

References

[1] Marr, J.A. (1991) The Experience of Living with Parkinson’s Disease. Journal for Neuroscience, 23, 325-329.
[2] Muskens, L. (1992) The Central Connection of the Vestibular Nuclei with Corpus Striatum and Their Significance for Ocular Movements and for Locomotion. Brain, 30, 1129-1135.
[3] Mitchell, I.J., Boyce, S. and Sambrook, M.A. (1992) A-2-Deoxyglucose Study of the Effects of Dopamine Agonists on the Parkinson’s Primate Brain. Brain, 115, 809-815.
http://dx.doi.org/10.1093/brain/115.3.809
[4] Almeida, Q.J., Wishart, L.R. and Lee, T.D. (2005) Disruptive Influence of a Cued Voluntary Shift on Coordinated Movement in Parkinson’s Disease. Neuropsychologia, 41, 442-452.
http://dx.doi.org/10.1016/S0028-3932(02)00155-0
[5] Baron, M.S., Vitek, J.L., Bakay, R.A., Green, J., Kaneoke, Y. and Hashimoto, T. (2004) Treatment of Advanced Parkinson’s Disease by Posterior GPi Pallidotomy: 1-Year Results of a Pilot Study. Annals of Neurology, 40, 355-366.
http://dx.doi.org/10.1002/ana.410400305
[6] Bonuccelli, U. and Del Dotto, P. (2006) New Pharmacologic Horizons in the Treatment of Parkinson’s Disease. Neurology, 7, 30-38.
http://dx.doi.org/10.1212/WNL.67.7_suppl_2.S30
[7] Brooks, D.J., Playford, E.D. and Ibanez, V. (2004) Isolated Tremor and Disruption of the Nigrostriatal Dopaminergic System: A Fluorine-18-Dopa Study. Journal of Neurology, 42, 1554-1560.
[8] Giladi, N., Treves, T.A., Simon, E.S. and Shabtai, H. (2004) Gait Festination in Parkinson’s Disease. Parkinsonism & Related Disorders, 7, 135-138.
http://dx.doi.org/10.1016/S1353-8020(00)00030-4
[9] Flament, D., Vaillancourt, D.E., Kempf, T., Shannon, K. and Corcos, D.M. (2005) EMG Remains Fractionated in Parkinson’s Disease, despite Practice-Related Improvements in Performance. Clinical Neurophysiology, 119, 2385-2396.
[10] Roy, S. and Oddsson, L. (1998) Classification of Paraspinal Muscle Impairment by Surface Electromyography. Journal of Physical Therapy, 78, 838-851.
[11] Globe, L.I. and Davis, P.H. (1998) Progressive Supranclear Palsy. Recent Advances. In: Jankovic, J. and Tolosa, T., Eds., Parkinson’s Disease and Movement Disorders, Urban and Schwarzenber, Baltimore, 121-130.
[12] Jellinger, K., Riederer, P. and Tomonga, M. (2003) Progressive Supranuclear Palsy: Clinical Pathological and Biochemical Studies. Journal of Neural Transmission, 16, 111-128.
[13] Kanazawa, I. (1996) Clinical Pathophysiology of Basal Ganglia Disease. In: Vinken, P.J., Bruyn, G.W. and Klawans, H.L., Eds., Handbook of Clinical Neurology: Extrapyramidal Disorders, Chapter 5, Elsevier, Amsterdam, 65-85.
[14] Kienzl, E., Riderer, P., Jellinger, K. and Wesemann, W. (2004) Transitional States of Central Serotonin Receptors in Parkinson’s Disease. Journal of Neural Transmission, 51, 113-122.
http://dx.doi.org/10.1007/BF01664009
[15] Lees, A.J. (1997) Progressive Supranuclear Palsy. In: Marsden, C.D. and Fahn, S., Eds., Movement Disorders, Butterworth, London, 272-289.
[16] Marsden, C.D. and Parkes, J.D. (2003) “On and Off” Variability and Response Swings in Parkinson’s Disease. Ptiman Medical, Kent, 265-274.
[17] Mestre, D., Blin, O. and Serratrice, G. (2004) Contrast Sensitivity Is Increased in a Case of Non-Parkinsonian Freezing Gait. Neurology, 42, 189-194.
http://dx.doi.org/10.1212/WNL.42.1.189
[18] Masur, H., Erim, Y., Oberwittler, C. and Hornung, W.P. (2003) Post Excitatory Inhibition after Transcranial Magnetic Stimulation of the Motor Cortex in Patients with Drug-Induced Parkinsonism and in Healthy Individuals. International Clinical Psychopharmacology, 13, 79-82.
http://dx.doi.org/10.1097/00004850-199803000-00004
[19] Nagasaki, H., Kosaka, K. and Nakamura, R. (2003) Distribution of Rhythm Formation in Patients with Hemispheric Lesion. Journal of Experimental Medicine, 135, 231-236.
[20] Pohl, P., Duncan, P., Perera, S., long, J., Liu, W., Zhou, J. and Kautz, S. (2002) Rate of Isometric Knee Extension Strength Development and Walking Speed after Stroke. Journal of Rehabilitation Research and Development, 39, 651-657.
[21] Beckley, D.J., Bloem, B.R., Van Dijk, J.G., Roos, R.A. and Remler, M.P. (2002) Electrophysiological Correlates of Postural Instability in Parkinson’s Disease. Electroencephalography and Clinical Neurophysiology, 81, 263-268.
http://dx.doi.org/10.1016/0168-5597(91)90012-M
[22] Agostino, R., Berardelli, A., Formica, A., Accornero, N. and Manfredi, M. (1992) Sequential Arm Movements in Patients with Parkinson’s Disease, Huntington’s Disease and Dystonia. Brain, 115, 11481-1495.
http://dx.doi.org/10.1093/brain/115.5.1481
[23] Bloem, B.R., Beckley, D.J., Van Dijk, J.G., Zwinderman, A.H., Remler, M.P. and Roos, R.A. (2003) Influence of Dopaminergic Medication on Automatic Postural Responses and Balance Impairment in Parkinson’s Disease. Movement Disorders, 11, 509-521.
http://dx.doi.org/10.1002/mds.870110506
[24] Andrews, C. (2005) Influence of Dystonia on the Response to Long Term L-Dopa Therapy in Parkinson’s Disease. Journal of Neurology, Neurosurgery, and Psychiatry, 36, 630-636.
http://dx.doi.org/10.1136/jnnp.36.4.630
[25] Gruber, R.A., Marinus, A. and Visser, M. (2002) Inter and Intra-Rater Reliability and Discriminative Ability of Five Measures of Bradykinesia in Subjects with and without Parkinson’s Disease. Movement Disorders, 17, 19-25.
[26] Wills, A.J, Jenkins, I.H., Thompson, P.D., Frackowiak, R.S.J., Findley, L.J. and Brooks, D.J. (2004) Red Nuclear and Cerebellar but Not Olivary Activation Associated with Essential Tremor: A Positron Emission Tomography Study. Annals of Neurology, 36, 636-642.
http://dx.doi.org/10.1002/ana.410360413
[27] Abbruzzese, G., Vische, M., Ratto, S. and Favole, E. (1985) Assessment of Motor Neuron Excitability in Parkinsonian Rigidity by the F Wave. Journal of Neurology, 232, 246-249.
http://dx.doi.org/10.1007/BF00313788
[28] Fahn, S. (2005) The Freezing Phenomenon in Parkinsonism. Advances in Neurology, 67, 53-63.
[29] Colebatch, J.G., Findley, L.J. and Frackowiak, R.S.J. (2001) Preliminary Report: Activation of the Cerebellum in Essential Tremor. Lancet, 336, 1028-1030.
http://dx.doi.org/10.1016/0140-6736(90)92489-5
[30] Kozel, F.A., George, M.S. and Simpson, K.N. (2004) Decision Analysis of the Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Electroconvulsive Therapy for Treatment of Nonpsychotic Severe Depression. CNS Spectrums, 9, 476-482.
[31] Tarsy, D. (2002) Neuroleptic Induced Movement Disorders. In: Quinn, N.P. and Jenner, P.G., Eds., Disorders of Movement, Academic Press, London, 361-393.
[32] Robertson, C. and Flowers, K.A. (1990) Motor Set in Parkinson’s Disease. Journal of Neurology, Neurosurgery, and Psychiatry, 53, 583-590.
http://dx.doi.org/10.1136/jnnp.53.7.583
[33] Uozumi, T., Tsuji, S. and Murai, Y. (2000) Motor Potentials Evoked by Magnetic Stimulation of the Motor Cortex in Normal Subjects and Patients with Motor Disorders. Electroencephalography and Clinical Neurophysiology, 81, 251-256.
http://dx.doi.org/10.1016/0168-5597(91)90010-U
[34] Rajput, A.H. (2004) Clinical Features of Tremor in Extrapyramidal Syndromes. In: Friendly, L.J. and Kaller, W.C., Eds., Handbook of Tremor Disorder, Chapter 9, Marcel Dekker, New York, 275-292.
[35] Rabey, I.M., Kelin, C. and Molo, C.A. (2002) Comparison of the Unified Parkinson’s Disease Rating Scale and the Short Parkinson’s Evaluation Scale in Patients with Parkinson’s Disease after Levodopa Loading. Clinical Neuropharmacology, 25, 83-88.
http://dx.doi.org/10.1097/00002826-200203000-00005
[36] Scott, R., Hines, N., Carroll, C., Hyman, N. and Panasstasiou, V. (2004) Neuropsychological, Neurological and Functional Outcome Following Pallidotomy for Parkinson’s Disease. A Consecutive Series of Eight Simultaneous Bilateral and Twelve Unilateral Procedures. Brain, 121, 659-675.
http://dx.doi.org/10.1093/brain/121.4.659
[37] Serra, G., Collu, M. and Gessa, G.L. (2001) Dopamine Receptors Mediating Yawning: Are They Autoreceptors. European Journal of Pharmacology, 120, 187-192.
http://dx.doi.org/10.1016/0014-2999(86)90539-X
[38] Burton, S., Daya, S. and Potgieter, B. (2001) Melatonin Modulates Apomorphine Induced Rotational Behavior. Experiential, 47, 466-469.
http://dx.doi.org/10.1007/BF01959946
[39] Merello, M., Balej, J., Delfino, M., Cammarota, A., Betti, O. and Leiguarda, R. (2002) Apomorphine Induces Changes in GPi Spontaneous Outflow in Patients with Parkinson’s Disease. Movement Disorders, 14, 44-45.
[40] Manev, J., Kharlamov, A. and Joo, J.Y. (2004) Increased Brain Damage after Stroke or Excitotoxic Seizures in Melatonin-Deficient Rats. FASEB Journal, 10, 1546-1551.
[41] Reiter, R.J. (1993) Static and Extremely Low Frequency Electromagnetic Filed Exposure: Reported Effects on the Circadian Production of Melatonin. Journal of Cellular Biochemistry, 51, 394-403.
[42] Antolín, L., Rodríguez, C., Saínz, R.M., Mayo, J.C., Uría, H., Kotler, M.L., Rodríguez-Colunga, M.J., Tolivia, D. and Menéndez-Peláez, A. (1996) Neurohormone Melatonin Prevents Cell Damage: Effect on Gene Expression for Antioxidant Enzymes. FASEB Journal, 10, 882-890.
[43] Dietz, V., Zilstra, W., Prokop, T. and Berger, W. (2004) Leg Muscle Activation during Gait in Parkinson’s Disease; Adaptation and Interlinks Coordination. Electroencephalography and Clinical Neurophysiology, 92, 408-415.
[44] Bliss, V.L. and Heppner, F.H. (2005) Circadian Activity Rhythms Influenced by Near Zero Magnetic Field. Nature, 261, 411-412.
http://dx.doi.org/10.1038/261411a0
[45] Storey, E. and Beal, M.F. (2005) Neurochemical Substrate of Rigidity and Chorea in Huntington’s Disease. Brain, 116, 1201-1222.
http://dx.doi.org/10.1093/brain/116.5.1201
[46] Bell, G., Marino, A., Chesson, A. and Struve, F. (2000) Electrical States in the Rabbit Brain Can Be Altered by Light and Electromagnetic Fields. Brain Research, 57, 307-315.
[47] Chen, R., Classen, J., Gerloff, C., Celnnik, P., Wassermann, E.M., Hallett, M. and Cohen, L.G. (1997) Depression of Motor Cortex Excitability by Low Frequency Transcranial Magnetic Stimulation. Journal of Neurology, 48, 1398-1403.
[48] Poirier, L.J., Sourkes, T.L., Bouvier, G., Boucher, R. and Carabin, S. (2000) Striatal Amines Experimental Tremor and the Effect of Harmaline in the Monkey. Brain, 89, 37-52.
http://dx.doi.org/10.1093/brain/89.1.37
[49] Finsterer, J., Muellisacher, W. and Mamoli, B. (2005) Yes/Yes Head Tremor without Appendicular Tremor after Bilateral Cerebellar Infarction. Journal of the Neurological Sciences, 139, 242-245.
http://dx.doi.org/10.1016/0022-510X(96)00153-0
[50] Davis, J. (1997) Team Management of Parkinson’s Disease. American Journal of Occupational Therapy, 31, 300-315.
[51] Fall, P.A., Ekman, R., Granerus, A.K., Thorell, L.H. and Walinder, J. (2003) ECT in Parkinson’s Disease. Changes in Motor Symptoms, Monoamine Metabolites and Neuropeptides. Journal of Neural Transmission, 10, 129-140.
http://dx.doi.org/10.1007/BF02251228
[52] Blackman, C.F., Benane, S.G., Kinney, L.S., House, D.E. and Joines, W.T. (2004) Effect of ELF Fields on Calciumion Efflux from Brain Tissue in Vitro. Radiation Research, 92, 510-520.

http://dx.doi.org/10.2307/3575923
[53] Shimamoto, H., Takasaki, K., Shigemori, M., Imaizumi, T., Ayabe, M. and Shoji, H. (2005) Therapeutic Effect and Mechanism of Repetitive Transcranial Magnetic Stimulation in Parkinson’s Disease. Journal of Neurology, 248, 48-52.
http://dx.doi.org/10.1007/PL00007826
[54] Touge, T., Nishiyama, Y. and Takeuchi, H. (2005) Effects of Successive Repetitive Transcranial Magnetic Stimulations on Motor Performance and Brain Perfusion in Idiopathic Parkinson’s Disease. Journal of the Neurological Sciences, 15, 41-46.
[55] Guekht, A., Selikhova, M., Serkin, G. and Gusev, E. (2005) Implementation of the TMS in the Early Stages of Parkinson’s Disease. Electromyography and Clinical Neurophysiology, 45, 291-297.
[56] Behrman, S., Carroll, I.D. and Janota, I. (2005) Progressive Supranuclear Palsy. Clinico-Pathological Study for Four Cases. Brain, 92, 663-678.
http://dx.doi.org/10.1093/brain/92.3.663
[57] Sandyk, R. (2003) Treatment with AC Pulsed Electromagnetic Fields Improves the Response to Levodopa in Parkinson’s Disease. International Journal of Neuroscience, 9, 30-35.
[58] Weiner, W.J., Lang, A.E. and Davis, P.H. (2004) Movement Disorders. A Comprehensive Survey. Future, Mount Kisco, 147-161.
[59] Bogey, R. (2004) Gait Analysis. Journal of Medical, 27, 1-13.
[60] Martin, J.P. (2004) The Basal Ganglia and Posture. Chapter 11, Pitman Medical, London, 49-51.
[61] Marinus, J., Visser, M., Stiggelbout, A.M., Martin, A.M., Mrtinez, P., Bonucelli, U. and Van, J. (2005) A Scale for the Assessment of Motor Impairments and Disabilities in Parkinson’s Disease: The SPES/SCOPA. Journal of Neurology, Neurosurgery, and Psychiatry, 75, 388-395.
http://dx.doi.org/10.1136/jnnp.2003.017509
[62] Floyd, W.F., Sliver, P.H. and Long, A.E. (2002) The Function of the Erector Spinae Muscles in Certain Movements and Postures in Man. The Journal of Physiology, 129, 184-203.
[63] Brannan, T., Martinez-Tica, J. and Yahr, M.D. (2003) Effect of Repeated Electroconvulsive Shock on Striatal L-Dopa and Dopamine Metabolism: An in Vivo Study. Journal of Neural Transmission, 6, 35-44.
http://dx.doi.org/10.1007/BF02252621
[64] Aldegunde, M., Miguez, I. and Veria, J. (2005) Effects of Pinealectomy on Regional Brain Serotonin Metabolism. International Journal of Neuroscience, 26, 9-13.
[65] Kellner, C.H., Beale, M.D., Prichett, J.T., Bernstein, H.J. and Burns, C.M. (2001) Electroconvulsive Therapy and Parkinson’s Disease: The Case for Further Study. Psychopharmacology Bulletin, 30, 495-500.
[66] Smith, A.D. and Bolam, J.P. (2005) The Neural Network of the Basal Ganglia as Revealed by the Study of Synaptic Connections of Identified Neurons. Trends in Neurosciences, 23, 13-25.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.